These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 3607784)

  • 1. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
    Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
    Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 10-Ethyl-10-deaza-aminopterin: structural design and biochemical, pharmacologic, and antitumor properties.
    Sirotnak FM; Schmid FA; Samuels LL; DeGraw JI
    NCI Monogr; 1987; (5):127-31. PubMed ID: 2448650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
    Sirotnak FM; Otter GM; Schmid FA
    Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracavitary therapy of murine ovarian cancer with cis-diamminedichloroplatinum(II) and 10-ethyl-10-deazaaminopterin incorporating systemic leucovorin protection.
    Sirotnak FM; Schmid FA; DeGraw JI
    Cancer Res; 1989 Jun; 49(11):2890-3. PubMed ID: 2785847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
    Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
    Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor properties of a new folate analog, 10-deaza-aminopterin, in mice.
    Sirotnak FM; DeGraw JI; Moccio DM; Dorick DM
    Cancer Treat Rep; 1978 Jul; 62(7):1047-52. PubMed ID: 688246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
    Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
    Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New folate analogs of the 10-deaza-aminopterin series: markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude mice.
    Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
    Cancer Treat Rep; 1985 May; 69(5):551-3. PubMed ID: 4005878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.
    Schabel FM; Trader MW; Laster WR; Corbett TH; Griswold DP
    Cancer Treat Rep; 1979; 63(9-10):1459-73. PubMed ID: 291480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy with cyclophosphamide and ftorafur against advanced L1210 murine leukemia.
    Grossie VB; Rosenblum MG; Loo TL
    Cancer Treat Rep; 1982 Aug; 66(8):1631-4. PubMed ID: 6809329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats.
    Yoshida M; Fujioka A; Nakano K; Kobunai T; Saito H; Toko T; Takeda S; Unemi N
    Anticancer Res; 1996; 16(3A):1155-9. PubMed ID: 8702227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and pharmacologic study of therapeutic synergism with cyclophosphamide plus methotrexate in murine L1210 leukemia.
    Klubes P; Cerna I
    Cancer Treat Rep; 1981; 65(1-2):107-14. PubMed ID: 7226161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL; Roberts BJ; Howard CT; Leopold WR
    Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased schedule-dependent synergism of vindesine versus vincristine in combination with methotrexate against L1210 leukemia.
    Chello PL; Sirotnak FM
    Cancer Treat Rep; 1981; 65(11-12):1049-53. PubMed ID: 7296551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined effect of HO-221 with various antitumor agents against L 1210 leukemia].
    Nakajima T; Masuda H; Okamoto T; Watanabe M; Yokoyama K; Yamada N; Tsukagoshi S; Taguchi T
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):555-62. PubMed ID: 2012397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental combination chemotherapy of pirarubicin with various antitumor drugs against P388 murine leukemia.
    Izumi H; Hirano S; Matsushita Y; Iguchi H; Tone H; Takeuchi T
    Cancer Biochem Biophys; 1994 Sep; 14(2):137-49. PubMed ID: 7889494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of pentoxifylline as a modulator of alkylating agent activity in vitro and in vivo.
    Teicher BA; Holden SA; Herman TS; Epelbaum R; Pardee AB; Dezube B
    Anticancer Res; 1991; 11(4):1555-60. PubMed ID: 1746913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells.
    Bowen D; Southerland WM; Johnson DH; Hawkins M; Hughes DE
    Cancer Detect Prev; 2000; 24(5):452-8. PubMed ID: 11129987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New folate analogs of the 10-deaza-aminopterin series. Further evidence for markedly increased antitumor efficacy compared with methotrexate in ascitic and solid murine tumor models.
    Sirotnak FM; DeGraw JI; Schmid FA; Goutas LJ; Moccio DM
    Cancer Chemother Pharmacol; 1984; 12(1):26-30. PubMed ID: 6690070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CMF or CAF combination chemotherapy for breast cancer].
    Ota J
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1886-90. PubMed ID: 8978791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.